Jazz Pharmaceuticals(JAZZ) - 2025 FY - Earnings Call Transcript

Jazz Pharmaceuticals (JAZZ) FY 2025 Conference September 03, 2025 09:30 AM ET Company ParticipantsMohit Bansal - MD & Co-Head of Therapeutics ResearchAmal Melhem-Bertrandt - VP - Oncology Therapy AreaPhilip Johnson - EVP & CFOMohit BansalThank you very much for joining us today. My name is Mohit Bansal. I'm one of the biopharma analysts here at Wells Fargo, and this is my first session, not the conference's first session. I'm happy to have the team from Jazz Pharmaceuticals with us. We have Phil Johnson, th ...